Serva Energy teams with research reactor to produce cancer-fighting Ac-225

June 27, 2023, 7:00AMNuclear News

Serva Energy has developed a research reactor–based method of actinium-225 production, the company announced on June 22, saying it “marks the first time a commercial entity has employed a conventional nuclear reactor to produce the lifesaving isotope—allowing for dozens of existing research reactors around the world to collaborate with Serva on increasing production of Actinium-225 without huge capital investments or delays for construction.”

To continue reading, log in or create a free account!

Related Articles

Beyond the grid

April 21, 2026, 11:54AMNuclear NewsCraig Piercy

In this month’s issue of Nuclear News, readers will find coverage of the “other” areas where nuclear technology is pushing into new frontiers. From marine nuclear propulsion to nuclear...